AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 288: E592-E598, 2005. First published November 16, 2004; doi:10.1152/ajpendo.00301.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/3/E592    most recent
00301.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raney, M. A.
Right arrow Articles by Turcotte, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raney, M. A.
Right arrow Articles by Turcotte, L. P.

AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction

Marcella A. Raney, Alice J. Yee, Mark K. Todd, and Lorraine P. Turcotte

Departments of Kinesiology and Biological Sciences, Diabetes Research Center, University of Southern California, Los Angeles, California

Submitted 8 July 2004 ; accepted in final form 11 November 2004

To determine the role of AMP-activated protein kinase (AMPK) activation on the regulation of fatty acid (FA) uptake and oxidation, we perfused rat hindquarters with 6 mM glucose, 10 µU/ml insulin, 550 µM palmitate, and [14C]palmitate during rest (R) or electrical stimulation (ES), inducing low-intensity (0.1 Hz) muscle contraction either with or without 2 mM 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside (AICAR). AICAR treatment significantly increased glucose and FA uptake during R (P < 0.05) but had no effect on either variable during ES (P > 0.05). AICAR treatment significantly increased total FA oxidation (P < 0.05) during both R (0.38 ± 0.11 vs. 0.89 ± 0.1 nmol·min–1·g–1) and ES (0.73 ± 0.11 vs. 2.01 ± 0.1 nmol·min–1·g–1), which was paralleled in both conditions by a significant increase and significant decrease in AMPK and acetyl-CoA carboxylase (ACC) activity, respectively (P < 0.05). Low-intensity muscle contraction increased glucose uptake, FA uptake, and total FA oxidation (P < 0.05) despite no change in AMPK (950.5 ± 35.9 vs. 1,067.7 ± 58.8 nmol·min–1·g–1) or ACC (51.2 ± 6.7 vs. 55.7 ± 2.0 nmol·min–1·g–1) activity from R to ES (P > 0.05). When contraction and AICAR treatment were combined, the AICAR-induced increase in AMPK activity (34%) did not account for the synergistic increase in FA oxidation (175%) observed under similar conditions. These results suggest that while AMPK-dependent mechanisms may regulate FA uptake and FA oxidation at rest, AMPK-independent mechanisms predominate during low-intensity muscle contraction.

electrical stimulation; perfused hindquarter; acetyl-coenzyme A carboxylase; malonyl-coenzyme A; cellular signaling; 5-aminoimidazole-4-carboxamide-1-{beta}-D-ribofuranoside; fatty acids



Address for reprint requests and other correspondence: L. P. Turcotte, Dept. of Kinesiology and Biological Sciences, Univ. of Southern California, 3560 Watt Way, PED 107, Los Angeles, CA 90089-0652 (E-mail:turcotte{at}usc.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Abbott, A. M. Edelman, and L. P. Turcotte
CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1724 - R1732.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. R. Steinberg and B. E. Kemp
AMPK in Health and Disease
Physiol Rev, July 1, 2009; 89(3): 1025 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Miura, Y. Kai, Y. Kamei, C. R. Bruce, N. Kubota, M. A. Febbraio, T. Kadowaki, and O. Ezaki
{alpha}2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E47 - E55.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Dzamko, J. D. Schertzer, J. G. Ryall, R. Steel, S. L. Macaulay, S. Wee, Z.-P. Chen, B. J. Michell, J. S. Oakhill, M. J. Watt, et al.
AMPK-independent pathways regulate skeletal muscle fatty acid oxidation
J. Physiol., December 1, 2008; 586(23): 5819 - 5831.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. A. Raney and L. P. Turcotte
Evidence for the involvement of CaMKII and AMPK in Ca2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle
J Appl Physiol, May 1, 2008; 104(5): 1366 - 1373.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. Rantzau, M. Christopher, and F. P. Alford
Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism
J Appl Physiol, February 1, 2008; 104(2): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. F. Kramer and L. J. Goodyear
Exercise, MAPK, and NF-{kappa}B signaling in skeletal muscle
J Appl Physiol, July 1, 2007; 103(1): 388 - 395.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Sriwijitkamol, D. K. Coletta, E. Wajcberg, G. B. Balbontin, S. M. Reyna, J. Barrientes, P. A. Eagan, C. P. Jenkinson, E. Cersosimo, R. A. DeFronzo, et al.
Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects With Type 2 Diabetes: A Time-Course and Dose-Response Study
Diabetes, March 1, 2007; 56(3): 836 - 848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. K. Todd, M. J. Watt, J. Le, A. L. Hevener, and L. P. Turcotte
Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E485 - E493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Raney and L. P. Turcotte
Regulation of contraction-induced FA uptake and oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1220 - E1227.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. B. Jorgensen, E. A. Richter, and J. F. P. Wojtaszewski
Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise
J. Physiol., July 1, 2006; 574(1): 17 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
G. K McConell, R. S Lee-Young, Z.-P. Chen, N. K Stepto, N. N Huynh, T. J Stephens, B. J Canny, and B. E Kemp
Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen
J. Physiol., October 15, 2005; 568(2): 665 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. C. Smith, C. R. Bruce, and D. J. Dyck
AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle
J. Physiol., June 1, 2005; 565(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. C. Smith, C. R. Bruce, and D. J. Dyck
AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle
J. Physiol., June 1, 2005; 565(2): 537 - 546.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.